Literature DB >> 16129872

Metformin's contraindications: needed for now.

I George Fantus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16129872      PMCID： PMC1188188          DOI： 10.1503/cmaj.050401

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

1.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 2.  The phantom of lactic acidosis due to metformin in patients with diabetes.

Authors:  Robert I Misbin
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

3.  Lactic acidosis in patients with diabetes treated with metformin.

Authors:  R I Misbin; L Green; B V Stadel; J L Gueriguian; A Gubbi; G A Fleming
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

Review 4.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

Review 5.  Metformin.

Authors:  C J Bailey; R C Turner
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

Review 6.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Arch Intern Med       Date:  2003-11-24

7.  The status of metformin in Canada.

Authors:  O J Lucis
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

Authors:  Nicolas Musi; Michael F Hirshman; Jonas Nygren; Monika Svanfeldt; Peter Bavenholm; Olav Rooyackers; Gaochao Zhou; Joanne M Williamson; Olle Ljunqvist; Suad Efendic; David E Moller; Anders Thorell; Laurie J Goodyear
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

Review 10.  Metformin and lactic acidosis: cause or coincidence? A review of case reports.

Authors:  A M E Stades; J T Heikens; D W Erkelens; F Holleman; J B L Hoekstra
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989
View more
  4 in total

1.  Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.

Authors:  Lawrence S Weisberg
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-11       Impact factor: 8.237

2.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

3.  Outcome of severe lactic acidosis associated with metformin accumulation.

Authors:  Sigrun Friesecke; Peter Abel; Markus Roser; Stephan B Felix; Soeren Runge
Journal:  Crit Care       Date:  2010-12-20       Impact factor: 9.097

4.  Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality.

Authors:  Dean T Eurich; Ross T Tsuyuki; Sumit R Majumdar; Finlay A McAlister; Richard Lewanczuk; Marcelo C Shibata; Jeffrey A Johnson
Journal:  Trials       Date:  2009-02-09       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.